Established in 2000, Taro UK has the benefit of Taro’s global resources. With 52 years of experience in developing, manufacturing, and marketing medications used in countries around the world, Taro looks forward to providing the UK with an expanding line of affordable, high-quality branded and generic pharmaceuticals.
This website contains valuable information about Taro UK products for dispensing doctors, pharmacists and consumers. Please visit often to learn more about the ways in which Taro can serve you.
August 10, 2015
FDA Approves Taro’s Keveyis™ (dichlorphenamide) 50 mg Tablets for Primary Hyperkalemic and Hypokalemic Periodic Paralysis
August 06, 2015
Taro Provides Results for Quarter Ended June 2015
July 30, 2015
Taro to Announce First Quarter Results on August 6, 2015
May 26, 2015
Taro Provides Results for Year Ended March 31, 2015
May 19, 2015
Taro to Announce Results for Year Ended March 31, 2015 on May 26, 2015